Kodiak Sciences Inc.
Kodiak Sciences Inc. (KOD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · KOD · as of Sep 30, 2025
Ownership Breakdown
131
Institutional Holders
▲ 29 vs Q2
$727.88M
Total Inst. Value
▲ $572.16M vs Q2
52.93M
Shares Outstanding
freeFloat 92.55%
44.47M
13F Shares Held
▲ 2.72M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
KOD largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP biological products, (no diagnostic substances) | 17.31M | 32.80% | 32.80% | $283.37B | Nov 14, 2025 | — held |
BLACKROCK, INC. biological products, (no diagnostic substances) | 2.95M | 5.59% | 5.59% | $48.33B | Nov 12, 2025 | ▼ 627.1K |
POINT72 ASSET MANAGEMENT, L.P. biological products, (no diagnostic substances) | 2.84M | 5.38% | 5.38% | $46.44B | Nov 14, 2025 | ▲ 2.38M |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 1.95M | 3.70% | 3.70% | $31.93B | Nov 7, 2025 | ▲ 128.0K |
ADAGE CAPITAL PARTNERS GP, L.L.C. biological products, (no diagnostic substances) | 1.33M | 2.53% | 2.53% | $21.85B | Nov 14, 2025 | ▼ 720.7K |
ICONIQ CAPITAL, LLC biological products, (no diagnostic substances) | 1.27M | 2.40% | 2.40% | $20.73B | Nov 14, 2025 | — held |
TCG CROSSOVER MANAGEMENT, LLC biological products, (no diagnostic substances) | 1.15M | 2.17% | 2.17% | $18.75B | Nov 17, 2025 | — held |
SILVERARC CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 1.00M | 1.89% | 1.89% | $16.37B | Nov 12, 2025 | ▲ 598.5K |
ACADIAN ASSET MANAGEMENT LLC biological products, (no diagnostic substances) | 969.9K | 1.84% | 1.84% | $15.87B | Nov 13, 2025 | ▼ 1000.0K |
STATE STREET CORP biological products, (no diagnostic substances) | 832.4K | 1.58% | 1.58% | $13.63B | Nov 14, 2025 | ▼ 4.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
20
Increased
+5.03M shares7
New Positions
first time holders15
Decreased
−3.94M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.09M
+5.03M / −3.94M
Net new holders
+12
7 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
KOD insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
9
Sell transactions
0.33
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
BORGESON JOHN A. Chief Financial Officer | Jun 4, 2026 | Sale | 25,896 | $34.01 | $880.7K | 216.0K | Form 4 ↗ |
BORGESON JOHN A. Chief Financial Officer | Jun 4, 2026 | Sale | 4,104 | $34.67 | $142.3K | 211.9K | Form 4 ↗ |
BORGESON JOHN A. Chief Financial Officer | Apr 2, 2026 | Sale | 12,692 | $39.14 | $496.8K | 200.6K | Form 4 ↗ |
BORGESON JOHN A. Chief Financial Officer | Apr 2, 2026 | Sale | 12,477 | $40.29 | $502.7K | 188.1K | Form 4 ↗ |
BORGESON JOHN A. Chief Financial Officer | Apr 2, 2026 | Sale | 4,231 | $40.88 | $173.0K | 183.9K | Form 4 ↗ |
BORGESON JOHN A. Chief Financial Officer | Apr 2, 2026 | Sale | 600 | $41.77 | $25.1K | 183.3K | Form 4 ↗ |
PERLROTH VICTOR Chairman and CEO | Mar 18, 2026 | Award | 175,000 | $25.00 | $4.38M | 175.0K | Form 4 ↗ |
BAKER BROS. ADVISORS LP
| Dec 18, 2025 | Purchase | 2,391,268 | $23.00 | $55.00M | 18.36M | Form 4 ↗ |
BAKER BROS. ADVISORS LP
| Dec 18, 2025 | Purchase | 217,428 | $23.00 | $5.00M | 1.56M | Form 4 ↗ |
BORGESON JOHN A. See Remarks | Jul 4, 2025 | Award | 250,000 | $3.95 | $987.5K | 250.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Kodiak Sciences Inc. (KOD) is primarily owned by institutional investors, who hold approximately 84.0% of total shares outstanding. Company insiders own approximately 7.45%, while retail and public investors account for the remaining 8.54%.
The largest institutional shareholder of Kodiak Sciences Inc. is BAKER BROS. ADVISORS LP, holding approximately 17.31 million shares — equal to 32.80% of outstanding shares — as of September 30, 2025.
A total of 131 institutional investors currently hold KOD stock, with a combined institutional value of approximately $727,876,832 as of the most recent 13F filing period.
Frequently asked questions
KOD ownershipKodiak Sciences Inc. (KOD) is primarily owned by institutional investors, who hold approximately 84.0% of shares. The largest shareholder is BAKER BROS. ADVISORS LP with a 32.80% stake. Company insiders hold 7.45%. Data sourced from SEC Form 13F as of September 30, 2025.